Kai-Li Liu Selected Research

hispidulin

6/2022	Retraction Note: Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
6/2022	Retraction Note to: Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway.
5/2019	Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway.
7/2018	Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
12/2017	Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
1/2017	Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai-Li Liu Research Topics

Disease

25	Hypertension (High Blood Pressure) 09/2022 - 01/2016
20	Inflammation (Inflammations) 09/2022 - 11/2011
13	Neoplasms (Cancer) 08/2021 - 05/2013
8	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2013
5	Neoplasm Metastasis (Metastasis) 07/2018 - 05/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 10/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2022 - 01/2017
3	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 07/2018
3	Cardiomegaly (Heart Hypertrophy) 01/2021 - 11/2017
3	Insulin Resistance 01/2016 - 04/2014
2	Chronic Renal Insufficiency 06/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
2	AIDS-Related Complex (ARC) 01/2022 - 01/2020
2	Renovascular Hypertension (Goldblatt Syndrome) 01/2021 - 11/2016
2	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 01/2016
2	Colitis 11/2019 - 09/2019
2	Ulcerative Colitis 11/2019 - 09/2019
2	Prehypertension 03/2018 - 01/2018
2	Obesity 01/2018 - 01/2018
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2018 - 01/2017
2	Glomerulonephritis 03/2008 - 03/2006
1	Pruritus (Itching) 06/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Mouth Neoplasms (Oral Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021

Drug/Important Bio-Agent (IBA)

15	SaltsIBA 09/2022 - 01/2016
13	CytokinesIBA 09/2022 - 05/2011
11	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022 - 02/2015
11	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2016
8	Docosahexaenoic AcidsIBA 08/2021 - 01/2013
7	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2015
6	hispidulinIBA 06/2022 - 01/2017
5	AntioxidantsIBA 01/2020 - 04/2014
5	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2015
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2022 - 05/2013
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 11/2017
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 11/2017
3	CeramidesIBA 06/2022 - 01/2017
3	EnzymesIBA 01/2021 - 11/2020
3	Biological ProductsIBA 01/2021 - 09/2014
3	ResveratrolIBA 09/2019 - 01/2017
3	FlavonoidsIBA 07/2018 - 01/2017
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2015 - 05/2013
3	andrographolideIBA 09/2014 - 11/2011
3	Heme Oxygenase-1IBA 08/2013 - 01/2013
2	Toll-Like Receptor 4IBA 01/2022 - 01/2018
2	NAD (NADH)IBA 01/2022 - 01/2020
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 02/2019
2	Growth InhibitorsIBA 08/2021 - 10/2017
2	ProstaglandinsIBA 04/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 11/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 10/2020
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 11/2016
2	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2014
2	CateninsIBA 09/2019 - 05/2016
2	IronIBA 01/2018 - 01/2016
2	polyglutamineIBA 01/2018 - 01/2017
2	Ataxin-3IBA 01/2018 - 01/2017
2	caffeic acidIBA 01/2018 - 01/2017
2	2-tert-butylhydroquinone (tert-butylhydroquinone)IBA 11/2017 - 10/2017
2	NF-kappa B (NF-kB)IBA 11/2016 - 02/2015
2	LipidsIBA 01/2016 - 05/2015
2	PalmitatesIBA 01/2016 - 05/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 05/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014 - 05/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2008 - 03/2006
1	Minocycline (Cyclops)FDA LinkGeneric 09/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2022
1	Fish OilsIBA 06/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Protein Kinase CIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Sincalide FDA Link 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Dasatinib (BMS 354825)FDA Link 10/2021
1	amsonic acid (DAS)IBA 10/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	deoxyhypusine synthaseIBA 01/2021
1	ribophorinIBA 01/2021
1	ApigeninIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2021
1	Superoxide Dismutase-1IBA 01/2021
1	Capsaicin (Zostrix)FDA Link 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	astaxanthine (astaxanthin)IBA 01/2021

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 06/2022 - 01/2020
2	Surgical Instruments (Clip) 01/2021 - 01/2021
1	Therapeutics 01/2022